Labyrinthopeptin A1, a unique lantibiotic peptide with broad-spectrum antiviral (HIV, HSV, influenza, RSV and DENV) activity

• Stephanie Gordts,
• Leentje Persoons,
• Sandra Claes,
• Geoffrey Férir,
• Mark Brönstrup,
• Roderich D. Süssmuth,
• Dominique Schols

Affiliations

Stephanie Gordts

Rega Institute for Medical Research, University of Leuven, Leuven, Belgium

Leentje Persoons

Rega Institute for Medical Research, University of Leuven, Leuven, Belgium

Sandra Claes

Rega Institute for Medical Research, University of Leuven, Leuven, Belgium

Geoffrey Férir

Rega Institute for Medical Research, University of Leuven, Leuven, Belgium

Mark Brönstrup

Helmholtz Center for Infection Research, Braunschweig, Germany

Roderich D. Süssmuth

Berlin Technical University, College II – Chemistry Institute, Berlin, Germany

Dominique Schols

Rega Institute for Medical Research, University of Leuven, Leuven, Belgium